| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human GLI1 recombinant protein (Position: Y800-Q1057) was used as the immunogen for the GLI1 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
GLI1 Antibody / Glioma-associated oncogene homolog 1 is an antibody targeting GLI1. Host: Rabbit. Polyclonal. Format: Lyophilized. Applications: WB, ELISA.
Key elements and design rationale
- Target: GLI1.
- Immunogen: E.coli-derived human GLI1 recombinant protein (Position: Y800-Q1057) was used as the immunogen for the GLI1 antibody..
- Species reactivity: Human, Mouse, Rat.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
GLI1 antibody detects Glioma-associated oncogene homolog 1, encoded by the GLI1 gene on chromosome 12q13.3. GLI1 antibody is used in research on developmental signaling, transcriptional regulation, and cancer biology. GLI1 is a zinc finger transcription factor and a key effector of the Hedgehog signaling pathway, which controls cell fate, proliferation, and differentiation during embryogenesis.
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
